ESR1 and neoplasm: Women with estrogen receptor (ER) positive, AR positive (ER+AR+) tumors are known to have better survival and more favorable clinicopathological features, like negative lymph node metastasis and lower tumor grade than women whose tumors are negative for AR (11).